Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Exp Biol ; 227(12)2024 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-38826150

RESUMEN

Gravid female lizards often experience reduced thermal preferences and impaired locomotor performance. These changes have been attributed to the physical burden of the clutch, but some authors have suggested that they may be due to physiological adjustments. We compared the thermal biology and locomotor performance of the lizard Liolaemus wiegmannii 1 week before and 1 week after oviposition. We found that gravid females had a thermal preference 1°C lower than that of non-gravid females. This was accompanied by a change in the thermal dependence of maximum running speed. The thermal optimum for locomotor performance was 2.6°C lower before oviposition than after. At relatively low temperatures (22 and 26°C), running speeds of females before oviposition were up to 31% higher than for females after oviposition. However, at temperatures above 26°C, females achieved similar maximum running speeds (∼1.5 m s-1) regardless of reproductive stage. The magnitude of the changes in thermal parameters and locomotor performance of L. wiegmannii females was independent of relative clutch mass (clutches weighed up to 89% of post-oviposition body mass). This suggests that the changes are not simply due to the clutch mass, but are also due to physiological adjustments. Liolaemus wiegmannii females simultaneously adjusted their own physiology in a short period in order to improve locomotor performance and allocated energy for embryonic development during late gravid stage. Our findings have implications for understanding the mechanisms underlying life histories of lizards on the fast extreme of the slow-fast continuum, where physiological exhaustion could play an important role.


Asunto(s)
Lagartos , Oviposición , Reproducción , Animales , Lagartos/fisiología , Femenino , Reproducción/fisiología , Oviposición/fisiología , Temperatura , Carrera/fisiología , Locomoción/fisiología
2.
Neuropathol Appl Neurobiol ; 43(3): 252-266, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26946354

RESUMEN

AIMS: MET gene amplification is rare in glioblastoma (GBM) and represents a potential target for MET inhibitors. An immunohistochemical screening may be useful to identify MET amplification. The aim of our study was to establish how MET immunolabelling correlates with MET amplification. METHODS: Three cohorts including 108 GBM (cohort 1, prospective), 104 GBM (cohort 2, retrospective) and 52 GBM (cohort 3, prospective) were investigated for MET expression by immunohistochemistry. MET amplification was assessed by comparative genomic hybridization on microarray (CGH-array) in all cohorts and by fluorescent in situ hybridization (FISH) in cohorts 2 and 3. Active form of MET was assessed using p-MET (Y1349) immunohistochemistry. RESULTS: Diffuse MET amplification detectable by CGH-array was associated with diffuse, strong MET immunolabelling (four cases in cohort 1 and one case in cohort 2). Focal MET amplification detectable only by FISH was observed in small foci of strongly immunopositive cells in two GBM (cohort 2). In both cohorts, MET amplification was never detected in GBM devoid of strongly immunopositive cells. MET overexpression, observed in 23% of unamplified GBM, was associated with a predominant weak-to-moderate staining intensity and with necrosis (P < 0.005). p-MET was detected in all MET-amplified GBM and in perinecrotic areas of nonamplified GBM. A strong MET immunostaining intensity, at least focal and distant from necrosis, showed 100% sensitivity and 84% specificity for predicting MET amplification in cohort 3. CONCLUSIONS: MET amplification is characterized by strongly immunopositive cells. Only GBM showing strong MET immunostaining is appropriate for the assessment of MET amplification.


Asunto(s)
Biomarcadores de Tumor/análisis , Neoplasias Encefálicas/genética , Glioblastoma/genética , Inmunohistoquímica/métodos , Proteínas Proto-Oncogénicas c-met/análisis , Adulto , Anciano , Biomarcadores de Tumor/genética , Estudios de Cohortes , Femenino , Amplificación de Genes , Humanos , Masculino , Persona de Mediana Edad , Proteínas Proto-Oncogénicas c-met/genética
3.
Cancer Genet ; 256-257: 158-161, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34157597

RESUMEN

The C797S mutation encoded by EGFR exon 20 is classically observed as a tertiary event in EGFR-mutant non-small-cell lung carcinoma (NSCLC) primarily treated by first generation tyrosine kinase inhibitors (TKI) and secondarily treated by third-generation TKI, such as osimertinib, if the EGFR-T790M resistance mutation is detected. Recently, significant prolonged progression free survival has been observed following first-line osimertinib, in EGFR-mutant NSLC. While mechanisms of molecular resistance to first-generation TKI have been well studied, little is known about resistance induced by primary third-generation TKI treatments. We report the case of a 65 year-old female treated by first-line osimertinib for a multimetastatic exon 19-EGFR-mutant NSCLC. EGFR-C797S resistance mutation and PIK3CA mutation were detected together with the remaining EGFR-exon 19 deletion. This observation provides insights of acquired resistance to first line-osimertinib. It also highlights the importance of making molecular platforms which perform routine EGFR testing in lung cancer aware of the kind of therapeutic protocols given to the patient. Indeed, for rapid results or low-costs procedures, some targeted methods specifically targeting T790M may be used at relapse and may overlook alterations such as C797S or PIK3CA mutations. Targeted next generation sequencing is therefore a recommended option.


Asunto(s)
Acrilamidas/uso terapéutico , Compuestos de Anilina/uso terapéutico , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/genética , Mutación/genética , Secuencia de Bases , Neoplasias Óseas/secundario , Resistencia a Antineoplásicos/genética , Receptores ErbB/genética , Resultado Fatal , Femenino , Estudios de Seguimiento , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Neoplasias Pulmonares/diagnóstico por imagen , Persona de Mediana Edad , Tomografía Computarizada por Rayos X
4.
Respir Med ; 137: 141-146, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29605198

RESUMEN

BACKGROUND: Little is known about the relationship between bone fragility and respiratory function. We hypothesized that women with osteoporosis or osteopenia, without cardio-pulmonary disease, have perturbations in the pattern of breathing and gas exchange. METHODS: In 44 women with bone fragility (BF, T score: < -1), and 20 anthropomorphically-matched control women (T score > -1) we compared pulmonary function tests, central respiratory drive (mouth occlusion pressure or P 0.1), pattern of breathing using optoelectronic plethysmograph and arterial blood gases at rest. RESULTS: Static pulmonary function was similar in BF subjects and controls. However, the arterial blood gas measurements differed significantly. The arterial pH was significantly higher in BF subjects than in controls (P < 0.001). The partial pressure of carbon dioxide (PaCO2) and oxygen (PaO2) in arterial blood were significantly lower in BF subjects than controls (P < 0.001 and P = 0.009, respectively). The BF subjects had a shorter inspiratory fraction compared with controls (P = 0.036). Moreover, T-scores were significantly inversely correlated with the alveolar-arterial gradient of oxygen (r = -0.5; P = 0.0003) and the arterial pH (r = -0.4; P = 0.002), and positively correlated with arterial PaO2 (r = 0.3; P = 0.01) and PaCO2 (r = 0.4; P = 0.002) among all subjects. CONCLUSION: In the absence of known cardio-pulmonary disease, BF is associated with statistically significant perturbations in gas exchange and alterations in the pattern of breathing including shortening of the inspiratory time.


Asunto(s)
Análisis de los Gases de la Sangre/métodos , Huesos/anomalías , Posmenopausia/fisiología , Intercambio Gaseoso Pulmonar/fisiología , Anciano , Densidad Ósea/fisiología , Desarrollo Óseo/fisiología , Huesos/patología , Dióxido de Carbono/sangre , Femenino , Humanos , Pulmón/fisiopatología , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Presión Parcial , Pletismografía/instrumentación , Estudios Prospectivos , Respiración , Pruebas de Función Respiratoria/métodos
5.
Nutr Hosp ; 27(6): 2116-21, 2012.
Artículo en Español | MEDLINE | ID: mdl-23588465

RESUMEN

Malnutrition in elderly people is one of the major syndromes associated to greater prevalence of chronic diseases and increased morbidity, hospital staying, and mortality. On the other hand, malnutrition in the fourth world is associated to another important risk factor, which is the poor economic status. The aim of this study was to elaborate a balanced menu for the elderly adjusting its price to the mean expense that this population dedicates to its feeding needs. Taking into account the Household expense for 2010 of the National Institute of Statistics, we established that the average price for each menu ought to be less than 5.57 € per day. Two type menus were elaborated, both adapted to this population and to the Mediterranean diet. The economic assessment was 5.02 € and 5.06 €, respectively. Given the prevalence of malnutrition in this population, it is essential being able to appropriately plan their feeding needs, at both the nutritional and economic levels.


Asunto(s)
Desnutrición/dietoterapia , Desnutrición/economía , Planificación de Menú/economía , Planificación de Menú/métodos , Estado Nutricional , Anciano , Costos y Análisis de Costo , Países en Desarrollo , Dieta Mediterránea/economía , Femenino , Alimentos/economía , Humanos , Masculino , Desnutrición/epidemiología , Prevalencia , Ingesta Diaria Recomendada , Factores Socioeconómicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA